DocGo Inc Dossier - Source-backed chat

DocGo Inc

DCGONASDAQ

SectorHealth Care

IndustryHealth Care Services

Beta (adjusted)0.98

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.39Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $39M

Enterprise Value $14M

Shares Outstanding 97.6M diluted

Next Earnings Date5 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

DocGo Inc. is undergoing a severe operational transition following the wind-down of its highly lucrative but controversial migrant-related municipal contracts. While the core medical transportation business remains robust and is achieving record quarterly revenues, the company's overall top-line has shrunk significantly, exposing fixed overhead and leading to substantial net losses and cash outflows. Furthermore, balance sheet pressures—highlighted by a minimum liquidity covenant non-compliance at year-end 2025 and subsequent going concern disclosures—introduce elevated risk. Although management has raised its 2026 revenue guidance to $300M–$315M and initiated a formal review of strategic alternatives, investors should remain on the sidelines until liquidity concerns are fully resolved and a clear path to sustainable profitability is established.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$1.00

Mean target$1.88

High · most bullish analyst$3.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.3020%

The bear case materializes if DocGo fails to reach an agreement with its lenders regarding its credit facility covenants, leading to restricted access to capital and accelerating going concern risks. Operational cash burn could worsen if EMT staffing shortages persist, forcing continued high overtime costs. Furthermore, if the strategic alternatives process concludes without a viable transaction, investor confidence will deteriorate further, driving the stock toward its historical lows.

Base CaseCentral scenario

$0.7555%

In the base case, DocGo slowly stabilizes its operations as migrant-related revenues completely exit the financials. Core medical transportation continues to grow at a high single-digit rate, and SteadyMD contributes steady virtual care revenues. However, high SG&A and fixed overhead costs limit near-term margin expansion, keeping adjusted EBITDA in negative territory for the first half of 2026 before reaching breakeven in the back half. Liquidity covenants are successfully renegotiated, but the stock remains range-bound due to lingering skepticism over long-term growth scalability.

Bull CaseUpside scenario

$1.5025%

The bull case relies on a successful turnaround driven by the rapid scaling of non-migrant Mobile Health services, particularly through the integration of the newly acquired SteadyMD platform and expansion of Remote Patient Monitoring (RPM). If DocGo can successfully lower its field overtime rates below 10% through aggressive EMT/paramedic recruitment, transport margins will recover. Additionally, the formal strategic alternatives process could culminate in a premium buyout or a highly favorable corporate restructuring.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Record performance in the core Medical Transportation segment, driven by strong demand in key US markets like New York, Texas, and Tennessee.
Strong underlying growth in non-migrant Mobile Health services, supported by the integration of SteadyMD and record Remote Patient Monitoring revenues.
Active strategic review process with an engaged investment bank to maximize shareholder value.

Key Investment Risks

Severe top-line contraction and margin compression due to the wind-down of high-margin migrant-related contracts.
Liquidity and covenant compliance challenges, resulting in substantial doubt about the company's ability to continue as a going concern prior to mitigation.
High operational cost structure, particularly premium overtime wages for field staff, which pressures gross margins.

Thesis Invalidation Triggers

Failure to secure a covenant waiver or amendment under the Credit Agreement.
A material downward revision of the fiscal year 2026 revenue guidance of $300M–$315M.
Termination of the strategic alternatives review process without any actionable transaction or buyout offer.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.